Moxifloxacin: Clinically compatible contrast agent for multiphoton imaging
SCIE
SCOPUS
- Title
- Moxifloxacin: Clinically compatible contrast agent for multiphoton imaging
- Authors
- Wang, T; JANG, WON HYUK; Lee, S; Yoon, CJ; Lee, JH; Kim, B; Hwang, S; Hong, CP; Yoon, Y; Lee, G; Le, VH; Bok, S; AHN, G ONE; Lee, J; Gho, YS; Chung, E; KIM, SUNGJEE; Jang, MH; Myung, SJ; Kim, MJ; So, PTC; KIM, KI HEAN
- Date Issued
- 2016-06-10
- Publisher
- NATURE PUBLISHING GROUP
- Abstract
- Multiphoton microscopy (MPM) is a nonlinear fluorescence microscopic technique widely used for cellular imaging of thick tissues and live animals in biological studies. However, MPM application to human tissues is limited by weak endogenous fluorescence in tissue and cytotoxicity of exogenous probes. Herein, we describe the applications of moxifloxacin, an FDA-approved antibiotic, as a cell-labeling agent for MPM. Moxifloxacin has bright intrinsic multiphoton fluorescence, good tissue penetration and high intracellular concentration. MPM with moxifloxacin was demonstrated in various cell lines, and animal tissues of cornea, skin, small intestine and bladder. Clinical application is promising since imaging based on moxifloxacin labeling could be 10 times faster than imaging based on endogenous fluorescence.
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/37973
- DOI
- 10.1038/SREP27142
- ISSN
- 2045-2322
- Article Type
- Article
- Citation
- Scientific Reports, vol. 6, page. 27142, 2016-06-10
- Files in This Item:
-
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.